ROBAXISAL Drug Patent Profile
When do Robaxisal patents expire, and when can generic versions of Robaxisal launch?
Robaxisal is a drug marketed by Robins Ah and is included in one NDA.
The generic ingredient in ROBAXISAL is aspirin; methocarbamol. There is one drug master file entry for this compound. Additional details are available on the aspirin; methocarbamol profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ROBAXISAL?
- What are the global sales for ROBAXISAL?
- What is Average Wholesale Price for ROBAXISAL?
Summary for ROBAXISAL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 4 |
| Patent Applications: | 1 |
| DailyMed Link: | ROBAXISAL at DailyMed |
US Patents and Regulatory Information for ROBAXISAL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Robins Ah | ROBAXISAL | aspirin; methocarbamol | TABLET;ORAL | 012281-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
